Listing 1 - 4 of 4 |
Sort by
|
Choose an application
The Food and Agriculture Organization of the United Nations has recently estimated that the world equid population exceeds 110 million. Working equids (horses, ponies, donkeys, and mules) remain essential to ensure the livelihood of poor communities around the world. In many developed countries, the equine industry has significant economical weight, with around 7 million horses in Europe alone. The close relationship between humans and equids and the fact that the athlete horse is the terrestrial mammal that travels the most worldwide after humans are important elements to consider in the transmission of pathogens and diseases, amongst equids and to other species. The potential effect of climate change on vector ecology and vector-borne diseases is also of concern for both human and animal health. In this Special Issue, we intend to explore our understanding of a panel of equine viruses, looking at their pathogenicity, their importance in terms of welfare and potential association with diseases, their economic importance and impact on performance, and how their identification can be helped by new technologies and methods.
hematophagous arthropod --- n/a --- abortion --- hepacivirus A --- Borna disease virus --- virus transmission --- virus stock propagation --- nucleoprotein --- influenza A viruses --- equine parvovirus-hepatitis --- neuropathogenic strain --- sequencing --- arbovirus --- virome --- transmission --- Equid alphaherpesvirus 1 --- interspecies transmission --- respiratory disease --- outbreak --- ORF34 --- ORF33 --- vaccine strategies --- ORF30 --- flavivirus --- in utero transmission --- non-primate hepacivirus --- risk factors --- Animal Rule --- equine herpesvirus type 1 --- African horse sickness --- polymerase activity --- horse parvovirus-CSF --- insects --- equine hepacivirus --- horse --- Parvoviridae --- Equid herpesviruses --- phylogeny --- ORF68 --- virus structure --- PCR --- Germany --- equine rhinitis virus A --- loss of performance --- ELISA --- myeloencephalopathy --- strain selection --- Venezuelan equine encephalitis virus --- equine Mx1 --- enteric disease --- cDNA cloned virus --- fetuses --- Eqcopivirus --- equine coronavirus --- Ireland --- MxA --- genital wart --- equine papillomaviruses --- equine parvovirus H --- replication --- virus neutralization --- MLST --- mosquito-borne virus --- seroprevalence --- equine influenza --- rabies --- evolution --- spike S1 protein --- hepatitis --- Thoroughbred racehorses --- vaccine --- bosavirus --- encephalitis --- West Nile virus --- horses
Choose an application
Hepatitis C virus (HCV), a major causative agent of chronic liver disease, is spread throughout the world and around 170 million people are persistently infected. In this volume, world-leading experts in the field of HCV research have compiled the most recent scientific advances to provide a comprehensive and very timely overview of the various facets of HCV. The book starts with a discussion of the possible origin of HCV and its spread among the human population. The focus of the subsequent chapters is on available cell culture and in vivo models before shifting to the molecular and cellular principles underlying the viral replication cycle. These chapters are complemented by insightful descriptions of the innate and adaptive immune responses to HCV as well as the virus-associated pathogenesis. Finally, the development of antiviral therapies, which is closely linked with progress in basic research, and the implementation of those therapies into present and future daily clinical practice are highlighted.
Hepacivirus. --- Hepatitis C virus. --- Hepatitis C virus --- Viral Vaccines --- Hepatitis, Viral, Human --- Flaviviridae --- Hepatitis Viruses --- Flaviviridae Infections --- Viruses --- Vaccines --- RNA Viruses --- Virus Diseases --- RNA Virus Infections --- Hepatitis --- Vertebrate Viruses --- Diseases --- Organisms --- Biological Products --- Liver Diseases --- Complex Mixtures --- Digestive System Diseases --- Chemicals and Drugs --- Viral Hepatitis Vaccines --- Hepacivirus --- Hepatitis C --- Biology --- Health & Biological Sciences --- Microbiology & Immunology --- Immunology. --- Medical virology. --- Immunobiology --- HCV (Hepatitis C virus) --- Medicine. --- Drug resistance. --- Virology. --- Hepatology. --- Biomedicine. --- Drug Resistance. --- Life sciences --- Serology --- Gastroenterology --- Microbiology --- Resistance to drugs --- Pharmacology --- Clinical sciences --- Medical profession --- Human biology --- Medical sciences --- Pathology --- Physicians --- Medical microbiology --- Virology --- Virus diseases --- Flaviviruses --- Hepatitis viruses --- Drug interactions. --- Clinical medicine. --- Interactions, Drug --- Drugs --- Medicine, Clinical --- Medicine --- Side effects
Choose an application
Chronic Hepatitis C Virus: Advances in Treatment, Promise for the Future documents the monumental advances that have been made in our understanding of chronic HCV during the past decade. The first section reviews the natural history of chronic HCV, how this virus can affect other organs in addition to the liver, and whether treating chronic HCV alters the natural history of this disease. Section 2 reviews the advances that have been made in the treatment of chronic HCV during the past decade with interferon based therapy. Separate chapters on response guided therapy and how to manage the adverse events associated with these medications provide the physician with the concepts required to more effectively treat chronic HCV now and in the future. As the genetics of virologic response have recently been elucidated, a chapter is devoted to helping the clinician understand how genes that modulate disease processes and their treatment are identified and utilized in clinical care. Section 3 deals with the future of HCV treatment and specific inhibitors of HCV. Specific chapters explain how targets for drugs are identified and how drugs are then developed and tested; how mutations of HCV develop and how anti-viral agents will affect this process; the most up to date data regarding the treatment of chronic HCV with peginterferon, ribavirin and anti-viral agents; and the potential to treat chronic HCV with just oral anti-viral agents and without peginterferon and ribavirin in the future. The final section of this book covers issues related to liver transplantation in patients with chronic HCV. Separate chapters review the natural history of chronic HCV in liver transplant recipients and the impact of utilizing HCV positive donors. The volume concludes with chapters that cover the treatment of chronic HCV both prior to and after liver transplantation with potent anti-viral agents. Chronic Hepatitis C Virus: Advances in Treatment, Promise for the Future is a valuable resource for all physicians caring for patients with chronic HCV.
Chronic diseases -- Treatment. --- Hepatitis C -- Treatment. --- Hepatitis, Chronic --- Flaviviridae --- Tissue Transplantation --- Hepatitis Viruses --- Hepatitis C --- Digestive System Surgical Procedures --- Anti-Infective Agents --- Organ Transplantation --- Transplantation --- Hepatitis --- Viruses --- Hepatitis, Viral, Human --- Therapeutic Uses --- Surgical Procedures, Operative --- Flaviviridae Infections --- RNA Viruses --- Vertebrate Viruses --- Liver Diseases --- Organisms --- Virus Diseases --- Pharmacologic Actions --- Analytical, Diagnostic and Therapeutic Techniques and Equipment --- RNA Virus Infections --- Digestive System Diseases --- Chemical Actions and Uses --- Diseases --- Chemicals and Drugs --- Hepatitis C, Chronic --- Liver Transplantation --- Antiviral Agents --- Hepacivirus --- Medicine --- Health & Biological Sciences --- Gastroenterology --- Hepatitis C. --- Liver --- Chronic diseases. --- Diseases. --- Diseases, Chronic --- NCDs (Noncommunicable diseases) --- Non-communicable diseases --- Non-infectious diseases --- Noncommunicable diseases --- Hepatitis, Non-A, non-B --- Non-A, non-B hepatitis, Parenterally-transmitted --- Parenterally-transmitted non-A, non-B hepatitis --- Medicine. --- Gastroenterology. --- Hepatology. --- Medicine & Public Health. --- Flaviviral diseases --- Hepatitis, Viral --- Clinical medicine. --- Internal medicine --- Digestive organs --- Medicine, Clinical --- Gastroenterology .
Choose an application
In 1947, Lerner and Watson showed that the cold-precipitable proteins in serum were gammaglobulins. These “cryoglobulins” were responsible for the corresponding clinical condition “cryoglobulinemia.” Meltzer and Franklin, in 1966, provided an accurate description of the typical clinical symptoms associated with cryoglobulinemia. Subsequent progress in this field was rather slow until the end of the 1980s, when cryoglobulinemia was definitively shown to be an extrahepatic manifestation of hepatitis C virus infection. The book is unique in its detailed presentation and fundamental approach. Highly qualified authors have contributed critical articles reviewing significant developments in our understanding of and therapeutic approach to HCV infection and cryoglobulinemia. The text is accompanied by striking color images and illustrations and highly informative tables. This comprehensive review of a systemic disease with a complex etiology is a valuable source of up-to-date, expert information not only for basic scientists and specialists in several disciplines but also for general practitioners as well as graduate and post-graduate students in clinical and medical research.
Cryoglobulinemia. --- Hepatitis C. --- Cryoglobulinemia --- Paraproteinemias --- Hemostatic Disorders --- Hepatitis C --- Flaviviridae --- Hepatitis, Chronic --- Vascular Diseases --- Medicine --- Hepatitis Viruses --- Blood Protein Disorders --- RNA Viruses --- Hepatitis --- Immunoproliferative Disorders --- Hepatitis, Viral, Human --- Health Occupations --- Cardiovascular Diseases --- Flaviviridae Infections --- Viruses --- Hemorrhagic Disorders --- Hematologic Diseases --- Virus Diseases --- Liver Diseases --- Diseases --- Vertebrate Viruses --- RNA Virus Infections --- Disciplines and Occupations --- Immune System Diseases --- Organisms --- Hemic and Lymphatic Diseases --- Digestive System Diseases --- Hepacivirus --- Hepatitis C, Chronic --- Pathology --- Vasculitis --- Health & Biological Sciences --- Urology & Nephrology --- Gastroenterology --- Cryogammaglobulinemia --- Hepatitis, Non-A, non-B --- Non-A, non-B hepatitis, Parenterally-transmitted --- Parenterally-transmitted non-A, non-B hepatitis --- Medicine. --- Internal medicine. --- Hepatology. --- Infectious diseases. --- Oncology. --- Rheumatology. --- Medicine & Public Health. --- Internal Medicine. --- Infectious Diseases. --- Flaviviral diseases --- Hepatitis, Viral --- Paraproteinemia --- Clinical medicine. --- Emerging infectious diseases. --- Oncology . --- Tumors --- Internal medicine --- Connective tissues --- Joints --- Emerging infections --- New infectious diseases --- Re-emerging infectious diseases --- Reemerging infectious diseases --- Communicable diseases --- Medicine, Internal --- Medicine, Clinical
Listing 1 - 4 of 4 |
Sort by
|